Daré Bioscience, Inc. (DARE) financial statements and ratios from SEC XBRL: revenue $1.03M (TTM), net margin -1300.7%, revenue growth 10429.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.03M |
| Net Margin | -1300.7% |
| Revenue Growth (YoY) | 10429.4% |
| EPS Growth (YoY) | 150.0% |
| FCF Growth (YoY) | -313.0% |
| Price / Sales | 60.11 |
| FCF Yield | -117.4% |
| Altman Z-Score | -8.78 (distress) |
| Sector P/E (Healthcare) | 21.7 |
DARE overview · DARE earnings · DARE KPIs · DARE investor relations · DARE ownership · DARE peers · DARE filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.